Autonomous robotic ultrasound system evaluated for thyroid nodule assessment
Prospective multicenter evaluation of an autonomous robotic ultrasound system integrated with AI-assisted thyroid nodule assessment
Autonomous ultrasound robots moving into prospective multicenter trials signal that AI-guided screening is graduating from lab demos to clinical evidence. Clinicians and medtech teams tracking diagnostic imaging automation can use this study as a reference point for regulatory-grade validation. Readers can compare its trial design with other autonomous imaging systems heading toward approval.
A prospective multicenter evaluation of an autonomous robotic ultrasound system with AI-assisted thyroid nodule assessment was published in npj Digital Medicine on 22 September 2026.
The study appears under DOI 10.1038/s41746-026-03260-7.
It examined the system's performance in a real-world clinical setting across multiple centers.Details of results are reported in the npj Digital Medicine article.
Prospective multicenter evaluation of an autonomous robotic ultrasound system integrated with AI-assisted thyroid nodule assessment
npj Digital Medicine, Published online: 22 September 2026; doi:10.1038/s41746-026-03260-7 Prospective multicenter evaluation of an autonomous robotic ultrasound system integrated with AI-assisted thyroid nodule assessment
This report is categorized under AITOP's "Papers" desk. Key entities and technical topics under continuous tracking include robotic ultrasound, thyroid nodule, medical AI, npj Digital Medicine.
Source attribution: curated from npj Digital Medicine (@Hui-Xiong Xu).